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Abstract 
 
Background & Aims: Liver disease is traditionally categorized as alcoholic and non-
alcoholic. We studied various risk factors predictive of advanced non-viral liver disease 
in general population and analyzed the interaction between these factors and alcohol 
consumption.  Methods: Persons without underlying liver disease who participated in 
the Health2000 or FINRISK studies 1992-2012 comprised a cohort of 41260 individuals. 
Pattern of alcohol consumption and metabolic, life-style-related and anthropometric 
parameters were analyzed with Cox regression analysis using severe liver disease 
hospitalization, cancer or death as end-point. Viral liver diseases were excluded.  
Results: 355 liver events occurred during the mean 12.4-year follow-up (511789 
person-years). In the multivariate model, age (HR 1.03, p=0.0083 for men, HR 1.04, 
p=0.0198 for women), waist-hip ratio (WHR) (HR 1.52, p=0.0006 for men, HR 1.58, 
p=0.0167 for women) PNPLA3 mutations (HR 1.9, p=0.024 for men, HR 2.7, p=0.0109 
for women) and weekly binge drinking (HR 2.4, p=0.0024 for men, HR 7.4, p<0.0001 for 
women) predicted development of severe liver disease. Among men, diabetes (HR 2.7, 
p=0.0002), average alcohol consumption (HR for 10g/d 1.1, p=0.0022) non-married 
status (HR 1.9, p=0.0397 for single and HR 2.4, p=0.0002 for widow/separated) and 
serum HDL (HR 2.2, p=0.0022) and non-HDL cholesterol (HR 1.2, p=0.0237) were 
additional risk factors. Alcohol intake increased the risk especially among persons with 
high WHR (p for interaction 0.009). Conclusions: Age, PNPLA3 haplotype and WHR 
increase the risk for development of severe liver disease. We found strong synergism 
between alcohol and central obesity. Binge drinking is an additional risk factor.  
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Introduction 
 
Liver cirrhosis is an end-result of several chronic liver diseases, e.g. viral hepatitis, 
autoimmune diseases, metabolic diseases and alcoholic liver disease (ALD). In Europe, 
ALD, non-alcoholic fatty liver disease (NAFLD) and viral hepatitis (B and C) are the 
leading causes of severe liver disease and liver-related deaths1. In case of viral and 
autoimmune hepatitis, the etiology is often easily diagnosed. Traditionally, ALD has 
been distinguished from NAFLD by exclusion of alcohol consumption exceeding certain 
threshold risk levels2. Alcohol is the only essential etiological factor in pure ALD3. 
However, other potential risk factors besides alcohol are poorly known4. The 
susceptibility to alcohol-induced liver damage is related to various factors including 
genetic determinants5. The risk factors for both ALD and NAFLD may coexist in same 
individuals6 and obesity and metabolic syndrome (MS) are frequent among patients 
with alcoholic liver cirrhosis7. Since the clinical picture and histological changes are 
similar in both diseases, it is often challenging to distinguish ALD from NAFLD6.  
Moreover, alcohol may modify other potential risk factors of liver disease. 
 
We aimed to determine the effect of genetic and life-style related risk factors of 
advanced liver disease in a large population-based cohort. Incidence of ALD and liver-
related mortality are high in Finland8, 9, 10, and the incidence has been increasing 
recently9. Thus, Finland offers a suitable ground for population-based studies on severe 
liver diseases. Aims of our study were to identify potential risk-factors and their 
interactions for development of non-viral advanced liver disease.  
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Methods 
 
The study population consisted of the population-based health examination surveys, 
FINRISK and Health 2000. Detailed descriptions of study protocols have been published 
previously11,12. FINRISK is a Finnish population survey on risk factors of various 
diseases. The surveys with questionnaires, physiological measurements and blood 
sampling have been carried out every 5 years since 1972 by the National Institute for 
Health and Welfare (previously National Public Health Institute) using a random and 
representative population sample. In the present study, we included FINRISK cohorts 
from 1992 (n=5972), 1997 (n=8330), 2002 (n=8544), 2007 (n=6112) and 2012 
(n=5676). The Health 2000 (n=6626) survey is also a comprehensive health interview 
and health examination study carried out in 2000-2001. DNA, serum and plasma 
samples have been collected in both the FINRISK and Health 2000 studies. Genotype 
data were available for a subset of participants (77%).   
 
Participants were asked to report how often they had consumed alcoholic beverages 
during the previous year and the average portion they had consumed per week. Average 
alcohol consumption (grams per day) was calculated as the sum of the number of drinks 
multiplied by the average alcohol content per type of alcoholic beverage. Average intake 
was converted into daily doses (10 g of ethanol per dose). Consumption of wine, beer, 
and spirits were assessed separately as well as frequency of binge drinking (at least 60 
grams per day) during the last 12 months (included in total average alcohol intake).  
Exercise was assessed by frequency of physical exercise for 20-30min until slightly out 
of breath and sweaty. Smoking was categorized as current, former and never smokers. 
Detailed description of the questionnaires is available at 
https://kite.fimm.fi/search#/browse . 
 
 
Elevated blood pressure was defined as systolic blood pressure exceeding 130 mmHg 
and/or diastolic pressure 85 mmHg, or by the use of antihypertensive medication.  
Diabetes mellitus was defined by fasting serum glucose ≥7.0 mmol/L, taking diabetes 
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medication, or a prior known diabetes diagnosis. The non-HDL cholesterol was 
calculated by subtracting HDL cholesterol from total serum cholesterol concentration.  
 
All residents of Finland have a unique personal identity code which is used in all 
national health registers. These codes were used to retrieve data of liver-related 
hospitalizations for the individuals in FINRISK and Health2000 surveys from the 
National Hospital Discharge register (HILMO), of liver cancers from the Finnish Cancer 
Registry, and of liver-related death from the national Causes-of-Death Register of 
Statistic Finland. These registries are nationwide, and follow-up of individuals living in 
Finland is virtually 100%. The liver diseases were defined by using the International 
Classification of diseases (ICD). The 10th revision has been used since year 1996. 
Persons with a diagnosis of any liver disease (ICD10:K70-K77, C22.0; ICD8/9: 570-573, 
155.0) at the baseline were excluded. Additionally, individuals with viral hepatitis 
(ICD10 codes B18) at baseline or during the-follow-up were excluded. The number of 
viral hepatitis diagnoses in the cohort was low (n=100). The follow-up was done until 
December 2013. A diagnosis of liver disease (ICD8: 571.0, 571.8, 571.9, 573.0, 573.9; 
ICD-9: 571.1, 571.2, 571.3, 571.5, 571.8; ICD10: K70.1, K70.2, K70.3, K70.4, K70.9, 
K72.0, K72.1, K72.9, K74.0, K74.1, K74.2, K74.6), liver-related death (ICD8/9:570-573, 
155.0; ICD10: K70-K77, C22.0) or liver cancer (C22.0) were designated as outcomes.  
 
The individuals included to the study had given signed informed consent for the study 
and future registry linkage. The study was approved by the Coordinating Ethical 
Committee of the Helsinki and Uusimaa Hospital District (previously studies also 
approved by the institutional review board of the National Public Health Institute). 
 
Cox regression analysis with backward stepwise elimination was performed, separately 
for men and women, with liver-related death, liver disease and liver cancer as the 
outcome, and with age,  marital status (single, married, divorced/widowed), education 
(low, average, high), employment (part- or full-time employment, retired, other), 
diabetes, waist-hip ratio (WHR), physical exercise, smoking status (former, current, 
never), alcohol consumption status (lifetime abstainer, current abstainer, user), average 
alcohol consumption (in doses of 10 g of ethanol), frequency of binge drinking (weekly, 
monthly, less often), serum levels of non-HDL cholesterol, HDL cholesterol and 
  
This article is protected by copyright. All rights reserved. 
triglycerides,  elevated blood pressure, mutations in patatin-like phospholipase-
containing domain 3 (PNPLA3), transmembrane 6 superfamily 2 (TM6SF2), HFE C282Y 
and H63D as independent variables. To analyze coherence in risk factor selection, we 
also performed Cox regression with forward stepwise selection. The proportional 
hazards assumption was tested using supremum test based on methods derived from 
cumulative sums of martingale residuals, and no violations were detected. Each 
independent risk factor was tested in age-adjusted subgroup analyses by diabetes 
status, alcohol intake (< vs > 30g/day for men or 20g/day for women), sex-specific WHR 
median, body mass index (BMI) (<20, 20-25, 25-30, >=30), marital status, and PNPLA3 
carrier status. Separate analyses were performed with alcohol-related liver disease 
(ICD8: 571.0; ICD-9: 571.1, 571.2, 571.3; ICD10:K70.1, K70.2, K70.3, K70.4, K70.9) or 
non-alcoholic liver disease (ICD8: 571.8, k71.9, 573.0, 573.9; ICD-9: 571.5, 571.8; ICD10: 
K72.0, K72.1, K72.9, K74.0, K74.1, K74.2, K74.6) as the outcome by a fixed-model Cox 
regression with the risk factors from the primary backward elimination model as 
independent variables. In addition, a similar fixed-model analysis was performed with 
liver-related death as the outcome. The relationship between average alcohol intake, 
stratified by sex and WHR tertiles, and the risk for liver disease was examined using the 
penalized spline smoothing method13 with adjustment for age. P-values <0.05 were 
considered statistically significant. Data were analyzed with SAS version 9.4, SPSS 
version 23 and R software version 3.2.5. 
 
Results 
 
After exclusion of persons with a known liver disease at baseline (n=288), and those 
with viral hepatitis (n=100), the final study cohort consisted of 41260 individuals. 
During the 511789 person-year follow-up, 355 incident liver events (245 in men and 
110 in women) occurred, including 196 liver-related deaths and 51 liver cancer cases. 
The baseline characteristics of the study cohort are presented in Table 1 and  a detailed 
description including details of alcohol consumption in supplementary files. 
 
The final multivariate model included age, diabetes, WHR, average alcohol consumption, 
binge drinking frequency, serum non-HDL and HDL cholesterol, PNPLA3 carrier status 
  
This article is protected by copyright. All rights reserved. 
and marital status for men and age, WHR, binge drinking frequency and PNPLA3 carrier 
status for women. The hazard ratios (HR) of each factor are presented in Tables 2 and 3. 
Forward stepwise selection Cox regression yielded the same independent variables as 
the backward model. 
 
In subgroup analysis, alcohol intake was a consistent risk factor across subgroups 
among both men (Figure 1) and women (Figure 2), and we found no signs of effect 
modification of BMI, diabetes, PNPLA3 or marital status on the association between 
average alcohol intake and liver disease risk. Detailed results of the subgroup analyses 
are presented in supplementary table. 
 
In a fixed-model Cox regression analysis considering the significant independent risk 
factors from the primary analysis using alcohol-related and non-alcoholic liver events as 
end-points, alcohol intake was not a risk factor for non-alcoholic liver disease (HR for 
10 g of ethanol 1.0, 95%CI 0.9-1.17 for male) but weekly binge drinking (HR 3.9, 95%CI 
1.3-11.6 for men and HR 8.1, 95%CI 1.6-40.4 for women) was. In analysis with liver 
death as the outcome (139 liver deaths among men and 57 among women) and 
significant independent risk factors from primary analysis, all the same risk factors 
remained significant among men (data not shown). Among women, binge drinking and 
WHR were non-significant probably due to low number of events.  
 
The interaction between alcohol intake and WHR is presented in Figures 3 and 4 
showing hazard ratios of alcohol intake among persons divided into WHR tertiles, that 
indicate a dose-dependent increase of the risk. One daily dose of alcohol in average 
increases the risk in men with the highest WHR as much as 4 doses among other men (p 
for interaction 0.009). 
 
 
Discussion 
 
Our large nationwide population-based study showed that age, high WHR, weekly binge 
drinking and PNPLA3 predict development of incident severe liver disease. 
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Furthermore, average alcohol intake is a risk factor among women with BMI >20 and 
among all men. Diabetes increases the risk of severe liver disease in all men and in 
women with alcohol consumption <20 g/day.  The harmful effect of alcohol intake is 
especially notable in men with high WHR, among whom even 1 daily dose of alcohol in 
average increased the risk of severe liver event over 5-fold.  
 
In a large Swedish study, alcohol was an independent risk factor for severe liver disease 
in a dose-dependent pattern without any threshold14. Thus, the safe limit of alcohol 
intake can be questioned. Such “safe” limits may also vary depending on other factors 
such as central obesity. In our cohort, alcohol consumption was an independent risk 
factor only among men. Weekly binge drinking was related to severe liver events among 
both sexes. This might reflect the pattern of alcohol consumption among women 
suggesting that high overall consumption among women in the cohort might be largely 
manifested as binge drinking. However, alcohol intake was a risk factor in several 
female subgroups, e.g. among women with BMI over 20. 
 
Weekly binge drinking predicted severe liver disease in both sexes. This has been 
reported previously15. In the present study, we found binge drinking as a risk factor for 
both alcohol-related and non-alcohol-related liver diseases even though total alcohol 
intake was a risk factor only for alcohol-related diagnosis among men. Binge drinking 
should be recognized as an important risk factor of severe liver disease irrespective of 
total alcohol intake and emphasized in general health promotion. 
 
Previous reports show differences between various alcoholic beverages in risk of liver 
cirrhosis16. A recent study from UK reported higher risk of liver cirrhosis among women 
drinking daily and outside meals regardless of the total alcohol intake17. Unfortunately, 
our data did not include details of drinking habits besides amount consumed and 
frequency of binge drinking. Furthermore, enough data of fractions of various alcoholic 
beverages consumed by study participants was not available for analysis. 
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Age was an independent risk factor in males and females. Age is related to more 
advanced stage of both ALD18 and NAFLD19. Age as a risk factor of severe liver events is 
comprehensible, since development of advanced liver disease takes time and older 
persons presumably have longer previous exposure to risk factors, e.g. lengthier history 
of alcohol consumption.  
 
WHR was an independent risk factor among men and women. Other parameters 
reflecting overweight have been recognised as risk factors previously. High BMI is a risk 
factor for ALD20 and has even a supra-additive effect on the risk of ALD21. Obesity is a 
known risk factor of NAFLD22. Overweight increases the risk of hepatocellular 
carcinoma (HCC), as well23. Various components of MS affect the risk of severe liver 
disease24.  Our model recognized WHR as an independent risk factor. WHR seems to be 
the most appropriate indicator of overweight and predisposition to MS in the context of 
liver disease, as reported previously25, 26, 27. 
 
Alcohol may modify the effects of other potential risk factors28. While high alcohol 
consumption increases the risk of MS29, 30, mild to moderate alcohol consumption is 
associated with lower MS risk28. However, in our cohort, even low alcohol intake 
increased the risk of severe liver disease among men with higher WHR, who 
presumably are also more susceptible to MS. Both HDL and non-HDL cholesterol were 
significant risk factors among men. Although high HDL level is usually considered 
beneficial, in context of liver disease this is contradictory. Higher HDL values are 
associated with elevated transaminase levels31. Furthermore, ethanol is a unique toxin, 
since it is capable of deteriorating almost all aspects of hepatic lipid metabolism leading 
to steatosis and changes in cholesterol synthesis and secretion32. The interaction 
between alcohol, lipid metabolism and the risk of liver disease warrants further studies. 
 
 
Variation in certain genes, e.g. PNPLA3, TM6SF2 and MBOAT7 are related to the risk of 
liver cirrhosis33, 34, 35. Due to low number of PNPLA3 homozygotes among our cohort, we 
grouped heterozygote (CG) and homozygote (GG) carriers together. In the present 
study, PNPLA3 mutation increased the risk of severe liver disease in both sexes. Thus, 
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the genetic profile together with other factors determines an individual’s risk of severe 
liver disease. Other gene variations did not enter the final model in the multivariate 
analysis as independent risk factors in this cohort. 
 
Single or divorced status of men as an independent risk factor for liver disease is 
difficult to explain. It hardly has any biological connection to liver disease. Instead, 
single and divorced males might simply consume more alcohol or live more sedentary 
lifestyle. However, marital status is related to mortality and morbidity in the context of 
other diseases. For example, unmarried men have an increased risk of both 
cardiovascular and non-cardiovascular mortality36. Likewise, single, divorced and 
widowed men have higher mortality from alcohol-related causes37. In our study, marital 
status of men was a significant risk factor only for alcohol-related but not for non-
alcohol-related liver diagnosis. 
 
In clinical practice, ALD diagnosis is often based on the history of patient’s alcohol 
consumption2.  Contrary to many other countries, great majority of liver diagnoses in 
Finland are categorized as alcohol-related10. Due to co-existence and interaction of 
various risk factors, the dichotomous distinction between alcoholic and non-alcoholic 
liver disease seems inappropriate. Our results emphasize the importance of counselling 
about all potential liver-related risk factors as whole in health promotion. In individual 
level, discourage of alcohol consumption in abdominally obese persons is particularly 
important due to supra-additive effect of ethanol intake on their liver disease risk. The 
genetic risk profile is generally not determined in practice, but all modifiable risk 
factors should be considered in health promotion. Our results provide insights for 
creating a liver-specific risk score for estimating the risk of individuals, but this 
warrants further studies. 
 
The strength of our study is the large number of persons in a representative nationwide 
cohort. The national health registries used in the study are considered precise38,39.  
Limitation of the study is lack of data of cases not requiring hospitalization. Thus, our 
results are only applicable to risk factors of severe liver disease. Since alcohol 
consumption and other habits were recorded only once at the time of the survey, the 
effects of possible changes in risk factors could not be studied. Persons with most 
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severe alcohol abuse might not participate in health surveys40.  Furthermore, details of 
alcohol drinking patterns besides type of alcoholic beverage consumed and frequency of 
binge drinking (e.g. drinking outside meals, daily versus episodic drinking) were not 
recorded. Although questionnaires concerning alcohol consumption were very detailed, 
the amounts were self-reported and  determination of actual intake can be somewhat 
challenging. This might influence the risk estimates of alcohol intake per dose. Some of 
the subgroup analyses might be underpowered as reflected in relatively wide 
confidence intervals. 
 
In conclusion, alcohol consumption, especially binge drinking and factors reflecting 
metabolic syndrome increase the risk of advanced liver disease among both sexes. 
Genetic predisposition (PNPLA3) increases the risk, as well. Additionally, marital status 
is related to the risk among men. The development of severe liver disease seems to 
result from interplay of various genetic and environmental factors making dichotomous 
distinction between alcoholic and non-alcoholic liver disease inappropriate. 
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Table 1. Baseline characteristics (mean and standard deviation) of the participants in the study.  
 All Men Women 
Number of persons 41260 19472 21788 
Number of liver events 355 245 110 
Age, (years) 49.6 (13.91) 50.0 (13.63) 49.2 (14.14) 
Marital status: 
(married/single/divorced,widow) 
n(%) 
29877 
(72.6)/ 
5452 (13.2)/ 
5841 (14.2) 
14774 (76.0)/ 
2849 (14.7)/ 
1805 (9.3) 
15103 (69.4)/ 
2603 (12.0)/ 
4036 (18.6) 
BMI† 26.8 (4.71) 27.1 (4.12) 26.5 (5.16) 
WHR‡ 0.9 (0.09) 1.0 (0.07) 0.9 (0.09) 
Smoking status: 
current/former/never  
n(%)  
9791 (24.0)/ 
9257 (22.6)/ 
21822 (53.4) 
5625 (29.23)/ 
5741 (29.84)/ 
7875 (40.93) 
4166 (19.26)/ 
3516 (16.26)/ 
13947 (64.48) 
Alcohol consumption: 
lifetime abstainer/current 
abstainer/user, n(%)  
3672 (9.0)/ 
1891 (4.7)/ 
35118 (86.3) 
936 (4.9)/ 
1034 (5.3)/ 
17281 (89.8) 
2736 (12.8)/ 
857 (4.0)/ 
17837 (83.2) 
Alcohol intake (grams/week) 75.5 (137.59) 114.8 (172.2) 38.6 (77.12) 
Binge drinking : 
less often/monthly/weekly 
n(%) 
13902 
(73.8)/ 
2786 (14.8)/ 
2149 (11.4) 
5239 (59.2)/ 
1889 (21.4)/ 
1717 (19.4) 
8663 (86.7)/ 
897 (8.9)/ 
432 (4.4) 
Physical exercise: 
Twice a week/2-4 times per 
month/less often,  
n (%) 
19993 
(57.4)/ 
9246 (26.5)/ 
5605 (16.1) 
9111 (55.5)/ 
4358 (26.5)/ 
2963 (18.0) 
10882 (59.1)/ 
4888 (26.6)/ 
2642 (14.4) 
Cholesterol (mmol/l) 5.5 (1.09) 5.6 (1.10) 5.5 (1.08) 
HDL§ cholesterol (mmol/l) 1.4 (0.38) 1.3 (0.34) 1.5 (0.39) 
Triglycerides (mmol/l) 1.5 (1.00) 1.7 (1.14) 1.3 (0.83) 
PNPLA3¶ rs738409 
CC/CG/GG 
19640 
(60.0)/ 
11406 
(34.9)/ 
1665 (5.1) 
9263 (60.1)/ 
5370 (34.9)/ 
771 (5.0) 
10377 (60.0)/ 
6036 (34.9)/ 
894 (5.1) 
Elevated blood pressure, n(%) 11536 
(28.0)/ 
29687 (72.0) 
4291 (22.0)/ 
15170 (78.0) 
7245 (33.3)/ 
14517 (66.7) 
Diabetes, n(%) 38121 
(92.4)/ 
3139 (7.6) 
17899 (91.9)/ 
1573 (8.1) 
20222 (91.8)/ 
1566 (7.2) 
†body mass index § high density lipoprotein ‡waist-hip ratio  
¶ patatin-like phospholipase-containing domain 3 gene   
  
This article is protected by copyright. All rights reserved. 
 
 
Table 2.  Predictors of advanced liver disease with hazard ratios (HR) and 95% confidence 
intervals (95%CI) among men by multivariate backward stepwise elimination Cox regression 
analysis.  
 
 
 
   HR 95%CI  p 
______________________________________________________________________________________________________________ 
age (years)   1.03 1.01-1.05  0.0083
  
marital status  1.85 1.03-3.33  0.0397 
(single versus married) 
 
marital status  
(divorced/widow versus married) 2.37 1.43-3.91    0.0008 
 
diabetes   2.72 1.61-4.61    0.0002 
 
WHR/SD†   1.52 1.20-1.92  0.0006
  
alcohol consumption (per 10 g ethanol) 1.13 1.08-1.19  <0.0001 
 
binge drinking weekly  2.36 1.35-4.11  0.0024 
 
serum HDL‡ cholesterol  2.21 1.33-3.67  0.0022 
 
serum non-HDL cholesterol   1.19 1.02-1.39  0.0237 
 
PNPLA3§ (CG or GG versus CC) 1.88 1.25-2.81    0.0024 
 
†waist-hip ratio/1 standard deviation 
‡high density lipoprotein 
§patatin-like phospholipase-containing domain 3 gene (rs738409)  
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Table 3. Predictors of advanced liver disease with hazard ratios (HR) and 95% confidence 
intervals (95%CI) among women by multivariate backward stepwise elimination Cox 
regression analysis.  
 
   HR 95%CI  p 
______________________________________________________________________________________________________________ 
age (years)   1.04 1.01-1.07  0.0198 
 
WHR/SD†   1.58 1.09-2.30  0.0167 
 
binge drinking weekly  7.38 2.85-19.12  <.0001 
 
PNPLA3‡ (CG or GG versus CC)  2.73 1.26-5.92  0.0109 
 
†waist-hip ratio/1 standard deviation 
‡patatin-like phospholipase-containing domain 3 gene (rs738409)  
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Figure 1. Alcohol intake as a risk factor for advanced liver disease among male 
subgroups.  Hazard ratios (HR) with 95% confidence intervals for 10g alcohol per day.  
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Figure 2. Alcohol intake as a risk factor for advanced liver disease among female 
subgroups. Hazard ratios (HR) with 95% confidence intervals for 10g alcohol per day. 
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Figure 3. The risk of advanced liver disease based on average alcohol intake in men 
grouped according to waist-hip ratio (WHR). 
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Figure 4. The risk of advanced liver disease based on average alcohol intake in women 
grouped according to waist-hip ratio (WHR). 
 
 
 
